Drug recall · January 22, 2020
Moxifloxacin Ophthalmic Solution USP recall
Why: Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.
- Lots / codes
Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.
- Quantity
- 100,080 bottles
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide in the U.S.
- Initiated
- December 2, 2019 · Voluntary: Firm initiated
- Classified
- January 17, 2020
- Reported
- January 22, 2020
- Ended
- November 22, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Moxifloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.